The results showed that when CLK1 was at a high expression level, pancreatic cancer patients with high expression levels of SRSF5 have a poorer prognosis than those with low SRSF5 expression levels (Fig. 4s, t, Additional file 4: Figure S4I.G,H). The gene discussed is SRSF5; the disease is familial pancreatic carcinoma.